Latest Articles
Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer - OncLive
Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer OncLive
Published: Nov. 7, 2024, 8:04 p.m.
Hurricane repairs, doctor's appointments to sudden 28 hour flight: Danielle Collins' wild journey to being a WTA Finals alternate - TennisUpToDate.com
Hurricane repairs, doctor's appointments to sudden 28 hour flight: Danielle Collins' wild journey to being a WTA Finals alternate TennisUpToDate.com
Published: Nov. 7, 2024, 9:09 a.m.
Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens - OncLive
Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens OncLive
Published: Nov. 5, 2024, 3:07 p.m.
Husband of woman who died just 3 days after cancer diagnosis asks government for big change to GP appointments - Lincolnshire Live
Husband of woman who died just 3 days after cancer diagnosis asks government for big change to GP appointments Lincolnshire Live
Published: Oct. 31, 2024, 4:09 a.m.
Brachytherapy With Modified Rotte-y Applicator for Inoperable Endometrial Cancer: A Case Report - Cureus
Brachytherapy With Modified Rotte-y Applicator for Inoperable Endometrial Cancer: A Case Report Cureus
Published: Oct. 27, 2024, 7:49 a.m.
Editorial: Women in Applied Genetic Epidemiology - Frontiers
Editorial: Women in Applied Genetic Epidemiology Frontiers
Published: Oct. 25, 2024, 9:12 p.m.
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer - OncLive
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer OncLive
Published: Oct. 24, 2024, 3:55 p.m.
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace
Published: Oct. 24, 2024, 11:46 a.m.
Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com
Approval From European Commission With Two New Indications in Gynecologic Cancers businesswire.com
Published: Oct. 24, 2024, 10:45 a.m.
Hers Appoints First Chief Medical Officer, Signals Expanded Focus on Women’s Healthcare - Femtech Insider
Hers Appoints First Chief Medical Officer, Signals Expanded Focus on Women’s Healthcare Femtech Insider
Published: Oct. 22, 2024, 11 a.m.
Link copied to clipboard!